Aurobindo Pharma Limited

₹1,804As of Sun 8 Nov 2026, 12:00 UTC
NSE:AUROPHARMAHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 8.77%
Div yield 0.39%
ROE 10.71%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.02
PE TTM 26.14
TSR TTM 58.40%
Mkt cap ₹1.038T
ROIC 10.66%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,219
23.00%
103.37%
Hold 11|8|12|4|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
20.29
20.31
20.63
20.59
12.96%
1.72%
(3.31%)
0.37%
Revenue₹B
65.13
67.52
67.56
68.11
0.32%
3.42%
3.61%
2.41%
Peers (US$11.03B)
Cap (US$)
PE
12.14B
39.36x
11.17B
46.83x
Capital
TTM
5Y
10Y
Leveragex
1.431
1.030
0.845
EBIT/Intx
0.825
0.091
0.087
Own earn%
(333.44)
129.87
130.83
Sh yield%
21.33
51.57
51.30
Owners
Insiders/Inst%
12.68
25.22
Short interest%
1.28
SBC / revenue%
0.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
5